tiprankstipranks
Trending News
More News >

YiChang HEC ChangJiang Pharmaceutical Announces Board Meeting for Annual Results

Story Highlights
YiChang HEC ChangJiang Pharmaceutical Announces Board Meeting for Annual Results

Don’t Miss TipRanks’ Half-Year Sale

YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H ( (HK:1558) ) has provided an update.

YiChang HEC ChangJiang Pharmaceutical Co., Ltd. has announced a board meeting scheduled for March 28, 2025, to discuss and approve the annual results for the year ending December 31, 2024, and consider the payment of a final dividend. This meeting is significant as it will determine the company’s financial standing and potential shareholder returns, impacting its market position and stakeholder interests.

More about YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H

YiChang HEC ChangJiang Pharmaceutical Co., Ltd. is a pharmaceutical company incorporated in the People’s Republic of China, focusing on the development, manufacturing, and distribution of pharmaceutical products.

YTD Price Performance: 3.56%

Average Trading Volume: 3,056,813

Technical Sentiment Consensus Rating: Sell

Current Market Cap: HK$8.82B

For detailed information about 1558 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1